Emergency Use Approval?21 Jul 2020 21:19
It looks obvious from the language ‘rapid as possible’ in today’s RNS, they are seeking ‘emergency use’ authorisation. So this could come very swiftly indeed:
‘.. As per the announcement of yesterday, the Company will be working with the regulators and other key groups to progress this potential COVID-19 treatment as rapidly as possible. As with any drug undergoing clinical trials, Synairgen will require regulatory approval before SNG001 can be marketed on a commercial basis.‘